Bio-Techne Corp (TECH)
63.22
-1.29
(-2.00%)
USD |
NASDAQ |
Apr 30, 16:00
63.22
0.00 (0.00%)
After-Hours: 20:00
Bio-Techne Research and Development Expense (Quarterly): 22.92M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 22.92M |
| September 30, 2023 | 24.00M |
| June 30, 2023 | 23.42M |
| March 31, 2023 | 22.71M |
| December 31, 2022 | 22.46M |
| September 30, 2022 | 23.90M |
| June 30, 2022 | 23.15M |
| March 31, 2022 | 21.74M |
| December 31, 2021 | 20.65M |
| September 30, 2021 | 21.60M |
| June 30, 2021 | 20.72M |
| March 31, 2021 | 17.05M |
| December 31, 2020 | 16.79M |
| September 30, 2020 | 16.04M |
| June 30, 2020 | 16.78M |
| March 31, 2020 | 15.95M |
| December 31, 2019 | 16.38M |
| September 30, 2019 | 16.08M |
| June 30, 2019 | 16.26M |
| March 31, 2019 | 15.55M |
| December 31, 2018 | 15.81M |
| September 30, 2018 | 14.79M |
| June 30, 2018 | 13.98M |
| March 31, 2018 | 13.89M |
| December 31, 2017 | 13.91M |
| Date | Value |
|---|---|
| September 30, 2017 | 13.55M |
| June 30, 2017 | 13.70M |
| March 31, 2017 | 13.77M |
| December 31, 2016 | 13.28M |
| September 30, 2016 | 12.76M |
| June 30, 2016 | 11.64M |
| March 31, 2016 | 11.24M |
| December 31, 2015 | 10.98M |
| September 30, 2015 | 11.32M |
| June 30, 2015 | 10.81M |
| March 31, 2015 | 10.86M |
| December 31, 2014 | 10.03M |
| September 30, 2014 | 9.149M |
| June 30, 2014 | 7.644M |
| March 31, 2014 | 7.676M |
| December 31, 2013 | 7.923M |
| September 30, 2013 | 7.702M |
| June 30, 2013 | 7.183M |
| March 31, 2013 | 7.219M |
| December 31, 2012 | 7.403M |
| September 30, 2012 | 7.452M |
| June 30, 2012 | 7.286M |
| March 31, 2012 | 7.122M |
| December 31, 2011 | 6.837M |
| September 30, 2011 | 6.667M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
15.95M
Minimum
Mar 2020
24.00M
Maximum
Sep 2023
19.93M
Average
20.72M
Median
Jun 2021
Research and Development Expense (Quarterly) Benchmarks
| Agilent Technologies Inc | 128.00M |
| Bio-Rad Laboratories Inc | 63.90M |
| Revvity Inc | 49.60M |
| Twist Bioscience Corp | 23.10M |
| AIM ImmunoTech Inc | 3.20M |